These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 8587443)

  • 41. [Certain metabolic indices of hypertrophied myocardium after exposure to embryonal organ-specific RNA].
    Skuba ND; Levkova NA
    Biull Eksp Biol Med; 1980 May; 89(5):609-12. PubMed ID: 6156723
    [No Abstract]   [Full Text] [Related]  

  • 42. A simple method for producing graded aortic insufficiencies in rats and subsequent development of cardiac hypertrophy.
    Uematsu T; Yamazaki T; Matsuno H; Hayashi Y; Nakashima M
    J Pharmacol Methods; 1989 Dec; 22(4):249-57. PubMed ID: 2559255
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Renal dopamine receptors are involved in the development of cardiac hypertrophy.
    Ganguly PK; Mukherjee K; Sahai A
    Mol Cell Biochem; 1995 Mar; 144(1):81-4. PubMed ID: 7791750
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Peripheral venous occlusion causing cardiac hypertrophy and changes in biological parameters in rats.
    Kawada S; Ishii N
    Eur J Appl Physiol; 2009 Apr; 105(6):909-17. PubMed ID: 19125275
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Soluble factor from the hypertrophied left ventricle of dogs in experimental hypertension: ability to stimulate protein metabolism of cultured heart cells.
    Honda M; Morioka S; Ohoka M; Yamada S; Moriyama K
    J Hypertens Suppl; 1988 Dec; 6(4):S125-7. PubMed ID: 2977155
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [On the nucleic acid content of the pathologically hypertrophied dog heart].
    Kleitke B; Sydow H
    Acta Biol Med Ger; 1965; 14(5):447-55. PubMed ID: 4220787
    [No Abstract]   [Full Text] [Related]  

  • 47. Surgical model of volume overload-induced ventricular myocardial hypertrophy (VHvo) to study a clinical problem in humans.
    Wittnich C; Belanger MP; Oh BS; Salerno TA
    J Invest Surg; 1991; 4(3):333-8. PubMed ID: 1832952
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Myocardial oxygen consumption and substrate uptake in man during physiological and pathological volume load.
    Heiss HW; Wink K; Barmeyer J; Keul J; Reindell H
    Basic Res Cardiol; 1977; 72(2-3):293-8. PubMed ID: 140676
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Cellular mechanisms of genetically determined hypertrophic cardiomyopathy in rats of line W/SSM].
    Nepomniashchikh LM; Semenov DE; Solov'eva NA; Salganik RI
    Biull Eksp Biol Med; 1994 Nov; 118(11):547-51. PubMed ID: 7888661
    [No Abstract]   [Full Text] [Related]  

  • 50. Endothelin and cardiac development.
    Luft FC
    J Mol Med (Berl); 2002 Nov; 80(11):685-6. PubMed ID: 12532950
    [No Abstract]   [Full Text] [Related]  

  • 51. Color Doppler Imaging, Endothelin-1, Corneal Biomechanics and Scleral Rigidity in Asymmetric Age-Related Macular Degeneration.
    Finzi A; Ottoboni S; Cellini M; Corcioni B; Gaudiano C; Fontana L
    Clin Ophthalmol; 2024; 18():2583-2591. PubMed ID: 39281979
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Myocardial protective effect of tezosentan, an endothelin receptor antagonist, for ischemia-reperfusion injury in experimental heart failure models.
    Ryu SM; Kim HJ; Cho KR; Jo WM
    J Korean Med Sci; 2009 Oct; 24(5):782-8. PubMed ID: 19794971
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Endothelin A receptor antagonists in congestive heart failure: blocking the beast while leaving the beauty untouched?
    Spieker LE; Noll G; Ruschitzka FT; Lüscher TF
    Heart Fail Rev; 2001 Dec; 6(4):301-15. PubMed ID: 11447305
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Peroxisome proliferator-activated receptor-gamma activators inhibit endothelin-1-related cardiac hypertrophy in rats.
    Sakai S; Miyauchi T; Irukayama-Tomobe Y; Ogata T; Goto K; Yamaguchi I
    Clin Sci (Lond); 2002 Aug; 103 Suppl 48():16S-20S. PubMed ID: 12193046
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Selective increase in endothelin-1 and endothelin A receptor subtype in the hypertrophied myocardium of the aorto-venacaval fistula rat.
    Brown LA; Nunez DJ; Brookes CI; Wilkins MR
    Cardiovasc Res; 1995 Jun; 29(6):768-74. PubMed ID: 7656280
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Increased production of endothelin-1 in the hypertrophied rat heart due to pressure overload.
    Yorikane R; Sakai S; Miyauchi T; Sakurai T; Sugishita Y; Goto K
    FEBS Lett; 1993 Oct; 332(1-2):31-4. PubMed ID: 8405444
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Altered production of endothelin-1 in the hypertrophied rat heart.
    Sakai S; Yorikane R; Miyauchi T; Sakurai T; Kasuya Y; Yamaguchi I; Sugishita Y; Goto K
    J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S452-5. PubMed ID: 8587443
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Possible involvement of endothelin-1 in cardiac hypertrophy.
    Yorikane R; Sakai S; Miyauchi T; Sakurai T; Goto K
    Arzneimittelforschung; 1994 Mar; 44(3A):412-5. PubMed ID: 8185715
    [TBL] [Abstract][Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.